Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Goodwill and Other Intangible Assets, Net

Goodwill and Other Intangible Assets, Net

6 Months Ended

Jun. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets, Net

6. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill is summarized by location as follows:

	June 30, 2016		December 31, 2015
American Burger Company	$	2,806,990	$	2,806,990
BGR: The Burger Joint		663,037		663,037
Little Big Burger		2,938,279		2,938,279
BTs Burger Joint		1,040,542		978,350
Just Fresh		495,755		425,151
Hooters South Africa		215,228		206,503
West End Wings UK		2,458,631		2,733,001
Hooters Pacific NW		1,950,828		1,950,828
Total	$	12,569,290	$	12,702,139

The changes in the carrying amount of goodwill are summarized as follows:

	Six Months Ended
	June 30, 2016			June 30, 2015
Beginning Balance	$	12,702,139		$	15,617,308
Acquisitions		70,604			663,037
Adjustments		62,192			-
Foreign currency translation (loss) gain		(265,645	)		(468,085	)
Ending Balance	$	12,569,290		$	15,812,260

Other intangible assets, consisting of franchise costs, trademarks and tradenames, is summarized by location as follows:

	Estimated
	Useful Life	June 30, 2016			December 31, 2015
Trademark, Tradenames:
Just Fresh	10 years	$	1,010,000		$	1,010,000
American Roadside Burger	10 years		1,786,930			1,786,930
BGR: The Burger Joint	Indefinite		1,430,000			1,430,000
Little Big Burger	Indefinite		1,550,000			1,550,000
			5,776,930			5,776,930
Franchise fees:
South Africa	20 years		298,847			286,732
Hooters Pacific NW	20 years		88,826			90,000
BGR: The Burger Joint	Indefinite		1,320,000			1,320,000
			1,707,673			1,696,732
Total Intangibles at cost			7,484,603			7,473,662
Accumulated amortization			(848,780	)		(696,726	)
Intangible assets, net		$	6,635,823		$	6,776,936

	Six Months Ended
	June 30, 2016		June 30 2015
Amortization expense	$	152,054	$	84,504

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details